1.45
price down icon0.68%   -0.01
 
loading

Ikena Oncology Inc Stock (IKNA) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
100.00%
-
0.659 1.185 2.004 5.313
Operating Expenses
19.24%
18.23
22.57 20.69 20.49 20.83
Operating Income/Loss
16.81%
-18.23
-21.91 -19.50 -18.49 -15.52
Nonoperating Income/Loss
2.107
- 2.16 1.375 1.296
Income/Loss From Continuing Operations Before Tax
17.97%
-16.12
-19.65 1.185 -17.11 -14.22
Income Tax Expense/Benefit
0.027
- - - -
Income/Loss From Continuing Operations After Tax
17.15%
-16.15
-19.49 -17.34 -17.11 -14.22
Net Income/Loss
17.15%
-16.15
-19.49 -17.34 -17.11 -14.22
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,259%
48.26
2.0461 43.44 39.29 36.26
Diluted Average Shares
2,259%
48.26
2.0461 43.44 39.29 36.26
Basic Earnings Per Share
17.50%
-0.33
-0.40 -0.40 -0.44 -0.39
Diluted Earnings Per Share
17.50%
-0.33
-0.40 -0.40 -0.44 -0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):